Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Construction of Type B Aortic Dissection Quality Control Platform and Risk Prediction Mechanism

NCT07745309 is registered in ClinicalTrials.gov with Chang Shu as lead sponsor.

NCT NCT07745309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07745309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Construction of Type B Aortic Dissection Quality Control Platform and Risk Prediction Mechanism
Lead sponsor
Chang Shu
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
August 31, 2029
Enrollment
2,375 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endovascular surgery, medical quality, prognostic early warning, stanford type b aortic dissection